T-Cell Depletion: Its evolution as a method for preventing GVHD and its potential as a platform for targeted immunotherapies

Track: BMT Tandem "Scientific" Meeting
Friday, February 28, 2014, 7:35 PM-8:15 PM
Texas B+D (Gaylord Texan)
Richard O'Reilly, MD , Department of Pediatrics, Bone Marrow Transplant Service, Memorial Sloan-Kettering Cancer Center, New York, NY
Disclosures:
Nothing To Disclose